Clinical Trial Update: Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating OGX-011 in combination with docetaxel and prednisone for men with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• OGX-011 (custirsen)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Achieve Life Sciences | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED